CollPlant Biotechnologies Ltd. (CLGN): Price and Financial Metrics

CollPlant Biotechnologies Ltd. (CLGN): $4.23

0.04 (+0.95%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

F

Add CLGN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#278 of 383

in industry

CLGN Price/Volume Stats

Current price $4.23 52-week high $6.99
Prev. close $4.19 52-week low $3.61
Day low $3.97 Volume 9,100
Day high $4.41 Avg. volume 10,172
50-day MA $4.39 Dividend yield N/A
200-day MA $5.05 Market Cap 48.45M

CLGN Stock Price Chart Interactive Chart >


CollPlant Biotechnologies Ltd. (CLGN) Company Bio


CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bio-printing of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants; VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.


CLGN Latest News Stream


Event/Time News Detail
Loading, please wait...

CLGN Latest Social Stream


Loading social stream, please wait...

View Full CLGN Social Stream

CLGN Price Returns

1-mo 8.46%
3-mo -16.40%
6-mo -26.58%
1-year -25.51%
3-year -78.29%
5-year -12.78%
YTD -33.80%
2023 -23.47%
2022 -48.96%
2021 51.90%
2020 88.95%
2019 35.71%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!